SFCM
ZNTL icon

Seven Fleet Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Seven Fleet Capital Management’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
317,600
+207,600
+189% +$829K 0.24% 47
2026
Q1 		$257K Buy
+110,000
New +$284K 0.08% 100

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Seven Fleet Capital Management's ZNTL Position: Q2 2026 in Review

Seven Fleet Capital Management increased its Zentalis Pharmaceuticals (ZNTL) stake by 189% in Q2 2026, buying an estimated $829K and bringing the position to 317,600 shares worth $1.45M. The position accounts for 0.24% of the portfolio, ranked #47.

Seven Fleet Capital Management first reported a position in ZNTL in Q1 2026 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • Seven Fleet Capital Management held 317,600 shares of Zentalis Pharmaceuticals worth $1.45M as of Q2 2026.
  • Seven Fleet Capital Management bought 207,600 Zentalis Pharmaceuticals shares in Q2 2026, an estimated $829K.
  • Zentalis Pharmaceuticals made up 0.24% of Seven Fleet Capital Management's portfolio in Q2 2026, its #47 holding.
  • Seven Fleet Capital Management first reported a position in Zentalis Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.